Atossa Therapeutics, Inc. (ATOS)
4.94
-0.04
(-0.80%)
USD |
NASDAQ |
Apr 10, 16:00
5.00
+0.06
(+1.21%)
After-Hours: 20:00
Atossa Therapeutics Cash from Financing (Quarterly) : 0.00 for Dec. 31, 2025
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | 1.349M |
| Plus Therapeutics, Inc. | 2.803M |
| Abeona Therapeutics, Inc. | 3.614M |
| Cell Source, Inc. | 0.80M |
| Kiora Pharmaceuticals, Inc. | 0.0003M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -10.54M |
| Cash from Investing (Quarterly) | -0.007M |
| Free Cash Flow | -29.78M |
| Free Cash Flow Per Share (Quarterly) | -1.225 |
| Free Cash Flow to Equity (Quarterly) | -10.55M |
| Free Cash Flow to Firm (Quarterly) | -10.55M |
| Free Cash Flow Yield | -15.56% |